183 related articles for article (PubMed ID: 28211453)
21. The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.
Holley SM; Ahmed AH; Srinivasan J; Murthy SE; Weiland GA; Oswald RE; Nowak LM
Biochemistry; 2012 May; 51(19):4015-27. PubMed ID: 22512472
[TBL] [Abstract][Full Text] [Related]
22. Kainate receptor agonists and antagonists mediate tolerance to kainic acid and reduce high-affinity GTPase activity in young, but not aged, rat hippocampus.
Hesp BR; Wrightson T; Mullaney I; Kerr DS
J Neurochem; 2004 Jul; 90(1):70-9. PubMed ID: 15198668
[TBL] [Abstract][Full Text] [Related]
23. The hidden energetics of ligand binding and activation in a glutamate receptor.
Lau AY; Roux B
Nat Struct Mol Biol; 2011 Mar; 18(3):283-7. PubMed ID: 21317895
[TBL] [Abstract][Full Text] [Related]
24. Role of conformational dynamics in α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor partial agonism.
Ramaswamy S; Cooper D; Poddar N; MacLean DM; Rambhadran A; Taylor JN; Uhm H; Landes CF; Jayaraman V
J Biol Chem; 2012 Dec; 287(52):43557-64. PubMed ID: 23115239
[TBL] [Abstract][Full Text] [Related]
25. Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.
Wang SY; Larsen Y; Navarrete CV; Jensen AA; Nielsen B; Al-Musaed A; Frydenvang K; Kastrup JS; Pickering DS; Clausen RP
J Med Chem; 2016 Mar; 59(5):2244-54. PubMed ID: 26862980
[TBL] [Abstract][Full Text] [Related]
26. Structural Mechanisms Underlying Activity Changes in an AMPA-type Glutamate Receptor Induced by Substitutions in Its Ligand-Binding Domain.
Sakakura M; Ohkubo Y; Oshima H; Re S; Ito M; Sugita Y; Takahashi H
Structure; 2019 Nov; 27(11):1698-1709.e5. PubMed ID: 31585769
[TBL] [Abstract][Full Text] [Related]
27. Oligomerization and ligand-binding properties of the ectodomain of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluRD.
Kuusinen A; Abele R; Madden DR; Keinänen K
J Biol Chem; 1999 Oct; 274(41):28937-43. PubMed ID: 10506139
[TBL] [Abstract][Full Text] [Related]
28. Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.
Madden DR; Cheng Q; Thiran S; Rajan S; Rigo F; Keinänen K; Reinelt S; Zimmermann H; Jayaraman V
Biochemistry; 2004 Dec; 43(50):15838-44. PubMed ID: 15595838
[TBL] [Abstract][Full Text] [Related]
29. Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.
Gill A; Birdsey-Benson A; Jones BL; Henderson LP; Madden DR
Biochemistry; 2008 Dec; 47(52):13831-41. PubMed ID: 19102704
[TBL] [Abstract][Full Text] [Related]
30. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors.
Stenum-Berg C; Musgaard M; Chavez-Abiega S; Thisted CL; Barrella L; Biggin PC; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):835-850. PubMed ID: 31582576
[TBL] [Abstract][Full Text] [Related]
31. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
[TBL] [Abstract][Full Text] [Related]
32. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
Armstrong N; Sun Y; Chen GQ; Gouaux E
Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
[TBL] [Abstract][Full Text] [Related]
33. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
Hansen KB; Tajima N; Risgaard R; Perszyk RE; Jørgensen L; Vance KM; Ogden KK; Clausen RP; Furukawa H; Traynelis SF
Mol Pharmacol; 2013 Jul; 84(1):114-27. PubMed ID: 23625947
[TBL] [Abstract][Full Text] [Related]
34. The tetrameric structure of a glutamate receptor channel.
Rosenmund C; Stern-Bach Y; Stevens CF
Science; 1998 Jun; 280(5369):1596-9. PubMed ID: 9616121
[TBL] [Abstract][Full Text] [Related]
35. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
36. Resolution, configurational assignment, and enantiopharmacology at glutamate receptors of 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid (ACPA) and demethyl-ACPA.
Johansen TN; Stensbøl TB; Nielsen B; Vogensen SB; Frydenvang K; Sløk FA; Bräüner-Osborne H; Madsen U; Krogsgaard-Larsen P
Chirality; 2001; 13(9):523-32. PubMed ID: 11579444
[TBL] [Abstract][Full Text] [Related]
37. Activation and Desensitization Mechanism of AMPA Receptor-TARP Complex by Cryo-EM.
Chen S; Zhao Y; Wang Y; Shekhar M; Tajkhorshid E; Gouaux E
Cell; 2017 Sep; 170(6):1234-1246.e14. PubMed ID: 28823560
[TBL] [Abstract][Full Text] [Related]
38. Ligands for glutamate receptors: design and therapeutic prospects.
Bräuner-Osborne H; Egebjerg J; Nielsen EO; Madsen U; Krogsgaard-Larsen P
J Med Chem; 2000 Jul; 43(14):2609-45. PubMed ID: 10893301
[No Abstract] [Full Text] [Related]
39. Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist.
Stensbøl TB; Jensen HS; Nielsen B; Johansen TN; Egebjerg J; Frydenvang K; Krogsgaard-Larsen P
Eur J Pharmacol; 2001 Jan; 411(3):245-53. PubMed ID: 11164381
[TBL] [Abstract][Full Text] [Related]
40. Chemical interplay in the mechanism of partial agonist activation in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Mankiewicz KA; Rambhadran A; Wathen L; Jayaraman V
Biochemistry; 2008 Jan; 47(1):398-404. PubMed ID: 18081322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
